Section
Money
Earnings analysis, pricing strategy, and financial dynamics
MoneyBioPharma Dive ↗
Lilly shares dipped, and Novo’s climbed, as Foundayo’s early trajectory diverged from that of oral…
MoneyBioPharma Dive ↗
The 185-acre site will be the company’s largest single investment to date, with a focus on small-volume …
MoneyEndpoints News ↗
A year after pulling its first try at an IPO, Odyssey Therapeutics is giving it another go. On Friday night, t…
MoneyBriefing
Seven pharma takeovers over $1B each in late March, totaling $29B, may have sidelined would‑be biotech IPOs af…
MoneyFierceBiotech ↗
A slow start to 2026 has put first-time biotech financings on course for their worst year since before the pan…
MoneyFierceBiotech ↗
Abbott's first-quarter numbers reflect is operational complexity.…
The Insider - Weekly pharma intelligence
Deals, negotiations, and policy analysis. Delivered when it matters.
No sponsored content. No noise. Unsubscribe anytime.